Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Schedule of Deferred Income Tax Assets (Details)

v3.25.0.1
Income Taxes - Schedule of Deferred Income Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:      
Net operating loss carryforwards $ 190,451 $ 138,735 $ 161,239
Research and development credits 115,651 55,492 36,886
Accruals and reserves 567 2,479 148
Property and equipment 2,892 3,110 4,260
Stock-based compensation 6,094 16,396 14,416
Goodwill 2,965 4,311 4,920
Intangibles 2,769 2,234 900
Lease Liability 515 664 600
Capitalized R&D 173,217 88,985 42,676
Total deferred tax assets 495,121 312,406 266,045
Valuation allowance (481,760) (295,740) (249,382)
Net deferred tax assets 13,361 16,666 16,663
Deferred tax liabilities      
Contractual agreement (13,361) (16,666) (16,663)
Total deferred tax liabilities (13,361) (16,666) (16,663)
Net deferred tax assets $ 0 $ 0 $ 0